Weikang Bio-Technology Group Co., Inc., Inc. Announces Fiscal Year 2011 Financial Results
4/2/2012 2:39:18 PM
More...
|
Weikang Bio-Technology Group Co., Inc. Completes HQ Relocation After Purchasing Building for $14 Million and Answers Questions About Its Third Quarter Financials
12/28/2011 10:49:18 AM
More...
|
Weikang Bio-Technology Group Co., Inc. Audit Committee Announces Results of Grant Thornton Report on Cash Balances
6/7/2011 1:18:56 PM
More...
|
Weikang Bio-Technology Group Co., Inc. Announces Fiscal 2010 Financial Results
3/22/2011 8:50:57 AM
More...
|
Weikang Bio-Technology Group Co., Inc. to Present at Rodman & Renshaw Annual China Investment Conference
3/4/2011 10:20:39 AM
More...
|
Weikang Bio-Technology Group Co., Inc. Announces Completion of $5.0 Million Private Placement
2/1/2011 6:55:58 AM
More...
|
Weikang Bio-Technology Group Co., Inc. Announces Inclusion of Ranitidine Hydrochloride Capsule on National Drug Reimbursement List
1/27/2011 6:48:47 AM
More...
|
Weikang Bio-Technology Group Co., Inc. Announces Fourth Quarter Revenue Contribution from Newest Sales Agents
1/24/2011 7:03:50 AM
More...
|
Weikang Bio-Technology Group Co., Inc. Expects to Report Fiscal 2010 Revenue of $77.8 Million and Net Income of $31.2 Million or $1.04 Earnings per Share
1/18/2011 10:34:12 AM
More...
|
Weikang Bio-Technology Group Co., Inc. Engages RedChip Companies to Lead Public and Investor Relations Efforts
1/12/2011 8:44:13 AM
More...
|
|